5-MeO-DBT
5-MeO-DBT.svg
5-MeO-DBT 3D BS.png
Clinical data
Other names5-methoxy DBT; N,N-Dibutyl-5-methoxy-1H-indole-3-ethanamine
Identifiers
  • N-Butyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]butan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H30N2O
Molar mass302.462 g·mol−1
3D model (JSmol)
  • CCCCN(CCCC)CCC1=CNC2=C1C=C(C=C2)OC
  • InChI=1S/C19H30N2O/c1-4-6-11-21(12-7-5-2)13-10-16-15-20-19-9-8-17(22-3)14-18(16)19/h8-9,14-15,20H,4-7,10-13H2,1-3H3
  • Key:WVGCRISHWANOTO-UHFFFAOYSA-N

5-MeO-DBT (5-Methoxy-N,N-dibutyltryptamine, 5-MeO-BET) is a rare substituted tryptamine derivative, which is thought to be a psychoactive substance and was identified in a designer drug sample by a forensic laboratory in Slovenia in March 2021,[1] although only analytical studies have been conducted and no pharmacological data is available.[2][3][4] It is nevertheless controlled under drug analogue legislation in a number of jurisdictions.

See also

References

  1. ^ "Analytical Report. 5-MeO-DBT" (PDF). Slovenia: Nacionalni Forenzični Laboratorij. 10 March 2021.
  2. ^ Brandt SD, Freeman S, Fleet IA, McGagh P, Alder JF (2005). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part II. Characterisation of the Speeter and Anthony synthetic route to N,N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR". Analyst. 130 (3): 330–344. doi:10.1039/b413014f.
  3. ^ Brandt SD, Freeman S, Fleet IA, Alder JF (2005). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part III. Characterisation of the Speeter and Anthony route to N,N-dialkylated tryptamines using CI-IT-MS-MS". Analyst. 130 (9): 1258–1262. doi:10.1039/b504001a.
  4. ^ Brandt SD, Martins CP (2010). "Analytical methods for psychoactive N,N-dialkylated tryptamines". Trends Anal. Chem. 29 (8): 858–869. doi:10.1016/j.trac.2010.04.008.